Is the revised International staging system for myeloma valid in a real world population?

导出 LinkOut

翻译打印收藏纠错

作者： Ieuan,Walker ^[1] ; Alice,Coady ^[1] ; Michael,Neat ^[2] ; Darius,Ladon ^[3] ; Reuben,Benjamin ^[4] ; Inas,El-Najjar ^[5] ; Majid,Kazmi ^[6] ; Steve,Schey ^[2] ; Matthew,Streetly ^[5]

作者单位： Guy's King's and St Thomas' School of Medicine, King's College London, London, UK. ^[1] Department of Haematology, Guy's and St Thomas' Hospital Trust, NHS, London, UK. ^[2] Department of Cancer Genetics, ViaPath, Guy's and St Thomas' Hospital Trust, NHS, London, UK. ^[3] Department of Cytogenetics, Viapath, Kings College Hospital, London, UK. ^[4] Kings Health Partners, London, UK. ^[5] Department of Haematology, King's College Hospital, London, UK. ^[6]

关键词 classifications multiple myeloma myeloma prognostic factors risk factors

主题词人类(Humans);多发性骨髓瘤(Multiple Myeloma);肿瘤分期(Neoplasm Staging)

DOI 10.1111/bjh.14341

PMID 27734463

发布时间 2018-02-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交